Cargando…

Screening for colorectal cancer: possible improvements by risk assessment evaluation?

Emerging results indicate that screening improves survival of patients with colorectal cancer. Therefore, screening programs are already implemented or are being considered for implementation in Asia, Europe and North America. At present, a great variety of screening methods are available including...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nielsen, Hans J, Jakobsen, Karen V, Christensen, IB J, Brünner, Nils
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Informa Healthcare 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205805/ https://www.ncbi.nlm.nih.gov/pubmed/21854094 http://dx.doi.org/10.3109/00365521.2011.610002

Ejemplares similares

An explorative analysis of ERCC1-19q13 copy number aberrations in a chemonaive stage III colorectal cancer cohort
por: Smith, David Hersi, et al.
Publicado: (2013)

High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients
por: Nielsen, Boye Schnack, et al.
Publicado: (2010)

Detection of serological biomarkers by proximity extension assay for detection of colorectal neoplasias in symptomatic individuals
por: Thorsen, Stine Buch, et al.
Publicado: (2013)

Early Detection and Recurrence of Colorectal Adenomas by Combination of Eight Cancer-Associated Biomarkers in Plasma
por: Rasmussen, Louise, et al.
Publicado: (2020)

Discovery and validation of a colorectal cancer classifier in a new blood test with improved performance for high-risk subjects
por: Croner, Lisa J., et al.
Publicado: (2017)

Mechanisms of Topoisomerase I (TOP1) Gene Copy Number Increase in a Stage III Colorectal Cancer Patient Cohort
por: Smith, David Hersi, et al.
Publicado: (2013)

Cathepsin X in serum from patients with colorectal cancer: relation to prognosis
por: Vizin, Tjasa, et al.
Publicado: (2012)

Data fusion in metabolomic cancer diagnostics
por: Bro, Rasmus, et al.
Publicado: (2012)

Circulating cell-free nucleosomes as biomarkers for early detection of colorectal cancer
por: Rasmussen, Louise, et al.
Publicado: (2017)

Prognostic and predictive value of cathepsin X in serum from colorectal cancer patients
por: Vižin, Tjaša, et al.
Publicado: (2014)

TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells: A potential novel approach to the treatment of metastatic colorectal cancer
por: Tarpgaard, Line S., et al.
Publicado: (2016)

Evaluating the Potential of Polygenic Risk Score to Improve Colorectal Cancer Screening
por: Arnau-Collell, Coral, et al.
Publicado: (2022)

Pre- and Perioperative Inflammatory Biomarkers in Older Patients Resected for Localized Colorectal Cancer: Associations with Complications and Prognosis
por: Dolin, Troels Gammeltoft, et al.
Publicado: (2021)

Blood-based Biomarkers at Large Bowel Endoscopy and Prediction of Future Malignancies
por: Kring, Thomas S., et al.
Publicado: (2015)

Triage May Improve Selection to Colonoscopy and Reduce the Number of Unnecessary Colonoscopies
por: Petersen, Mathias M., et al.
Publicado: (2020)

Gel-Based Proteomics of Clinical Samples Identifies Potential Serological Biomarkers for Early Detection of Colorectal Cancer
por: Thorsen, Stine F., et al.
Publicado: (2019)

Urokinase-type plasminogen activator receptor (uPAR) on tumor-associated macrophages is a marker of poor prognosis in colorectal cancer
por: Illemann, Martin, et al.
Publicado: (2014)

ABCG2 Protein Levels and Association to Response to First-Line Irinotecan-Based Therapy for Patients with Metastatic Colorectal Cancer
por: Palshof, Jesper Andreas, et al.
Publicado: (2020)

Measuring ERCC1 protein expression in cancer specimens: Validation of a novel antibody
por: Smith, David Hersi, et al.
Publicado: (2014)

Colorectal Cancer Screening for Average-Risk North Americans: An Economic Evaluation
por: Heitman, Steven J., et al.
Publicado: (2010)

Correction: Colorectal Cancer Screening for Average-Risk North Americans: An Economic Evaluation
por: Heitman, Steven J., et al.
Publicado: (2012)

Flow Cytometric Bivariate Analysis of DNA and Cytokeratin in Colorectal Cancer
por: Post, Carolin, et al.
Publicado: (2002)

Colorectal Cancer Screening: Impact of COVID-19 Pandemic and Possible Consequences
por: Harber, Isabelle, et al.
Publicado: (2021)

Improved risk scoring systems for colorectal cancer screening in Shanghai, China
por: Wu, Wei‐Miao, et al.
Publicado: (2022)

Lack of relationship between TIMP-1 tumour cell immunoreactivity, treatment efficacy and prognosis in patients with advanced epithelial ovarian cancer
por: Steffensen, Karina Dahl, et al.
Publicado: (2010)

Implications of ABCG2 Expression on Irinotecan Treatment of Colorectal Cancer Patients: A Review
por: Nielsen, Dorte Lisbet, et al.
Publicado: (2017)

Evaluability assessment: An application in a complex community improvement setting
por: Brunner, Richard, et al.
Publicado: (2019)

Evaluation of a panel of tumor-specific differentially-methylated DNA regions in IRF4, IKZF1 and BCAT1 for blood-based detection of colorectal cancer
por: Young, Graeme P., et al.
Publicado: (2021)

Economic evaluations of colorectal cancer screening: A systematic review and quality assessment
por: Ramos, Marcela Castro, et al.
Publicado: (2023)

Circulating tumor DNA: Response Evaluation Criteria in Solid Tumors – can we RECIST? Focus on colorectal cancer
por: Spindler, Karen-Lise Garm, et al.
Publicado: (2023)

uPAR Expression Pattern in Patients with Urothelial Carcinoma of the Bladder – Possible Clinical Implications
por: Dohn, Line Hammer, et al.
Publicado: (2015)

Improving risk assessments in conservation ecology
por: Ono, Kotaro, et al.
Publicado: (2019)

Risk Stratification Score Improves Sensitivity for Advanced Colorectal Neoplasia in Colorectal Cancer Screening: The Oshima Study Workgroup
por: Sekiguchi, Masau, et al.
Publicado: (2021)

Age‐stratified reference intervals unlock the clinical potential of circulating cell‐free DNA as a biomarker of poor outcome for healthy individuals and patients with colorectal cancer
por: Ørntoft, Mai‐Britt Worm, et al.
Publicado: (2020)

Primary care colorectal cancer screening correlates with breast cancer screening: implications for colorectal cancer screening improvement interventions
por: Weiss, Jennifer M., et al.
Publicado: (2018)

A risk scoring system for advanced colorectal neoplasia in high-risk participants to improve current colorectal cancer screening in Tianjin, China
por: Yuan, Zhen, et al.
Publicado: (2022)

Risk–Benefit Assessment of an Increase in the Iodine Fortification Level of Foods in Denmark—A Pilot Study
por: Jakobsen, Lea Sletting, et al.
Publicado: (2022)

Assessment of quality in screening colonoscopy for colorectal cancer
por: Gonçalves, Ana Rita, et al.
Publicado: (2011)

Assessment of Quantitative and Allelic MGMT Methylation Patterns as a Prognostic Marker in Glioblastoma
por: Kristensen, Lasse S., et al.
Publicado: (2016)

Colorectal cancer development and advances in screening
por: Simon, Karen
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6ub050es58iav9hcpe42uf27hg